Peptris Raises $1M in Pre-Seed Funding to Transform Drug Discovery using AI Technology

Share This Post

Tech News Summary:

  • Peptris Technologies Private Limited, a Bengaluru-based AI drug discovery company, has secured a pre-seed round investment of $1 million led by Speciale Invest.
  • Peptris aims to advance AI-driven solutions in drug discovery, particularly in developing novel therapies for non-drug targets such as oncology, inflammation, and rare diseases.
  • The company’s strategic position at the intersection of pharmaceutical technology and expertise, along with their focus on rare diseases, shows the potential to revolutionize healthcare globally.

Peptris, a cutting-edge biotech company, has announced that it has secured $1 million in pre-seed funding to revolutionize drug discovery using artificial intelligence (AI). The funding round was led by top-tier venture capital firms and prominent angel investors in the healthcare and biotech space.

Peptris is leveraging advanced AI algorithms to identify and develop novel therapeutic peptides for a wide range of diseases, including cancer, diabetes, and neurological disorders. The company’s proprietary technology platform provides a rapid and cost-effective approach to drug discovery, significantly reducing the time and resources required to bring new therapies to market.

“We are thrilled to have the support of leading investors who share our vision for transforming the way drugs are discovered and developed,” said Dr. Sarah Chen, co-founder and CEO of Peptris. “This funding will enable us to accelerate the expansion of our AI platform and advance our pipeline of innovative peptide-based therapeutics.”

Peptris’ approach to drug discovery has the potential to address unmet medical needs and improve patient outcomes by delivering breakthrough treatments that traditional methods have struggled to achieve. By harnessing the power of AI, the company aims to unlock the full potential of peptides as a versatile and effective class of therapeutic agents.

“We are excited to partner with Peptris as they redefine the drug discovery process using AI,” said a spokesperson for the lead investor. “Their innovative approach has the potential to revolutionize the biotech industry and bring much-needed advancements to healthcare.”

With the pre-seed funding in place, Peptris is well-positioned to advance its research and development efforts and establish strategic partnerships with pharmaceutical companies and research institutions. The company is poised to play a pivotal role in shaping the future of drug discovery and usher in a new era of precision medicine.

Read More:

Partnership Between Mitsubishi Electric and Nozomi Networks Strengthens Operational Technology Security Business

Mitsubishi Electric and Nozomi Networks Partnership Mitsubishi Electric and Nozomi...

Solidion Technology Inc. Completes $3.85 Million Private Placement Transaction

**Summary:** 1. Solidion TechnologyInc. has announced a private placement deal...

Analyzing the Effects of the EU’s AI Act on Tech Companies in the UK

Breaking Down the Impact of the EU’s AI Act...

Tech in Agriculture: Roundtable Discusses Innovations on the Ranch

Summary of Tech on the Ranch Roundtable Discussion: ...

Are SMEs Prioritizing Tech Investments Over Security Measures?

SMEs Dive Into Tech Investments, But Are...

Spotify Introduces Music Videos for Premium Members in Chosen Markets

3 Summaries of Spotify Unveils Music Videos for Premium...

Shearwater to Monitor Production at Equinor’s Two Oil Platforms

Shearwater GeoServices secures 4D monitoring projects from Equinor for...

Regaining Europe’s Competitive Edge in Innovation: Addressing the Innovation Lag

Europe’s Innovation Lag: How Can We Regain Our Competitive...

Related Posts

Government Warns of AI-Generated Content: Learn More about the Issue

Government issued an advisory on AI-generated content. All AI-generated content...

Africa Faces Internet Crisis: Extensive Outage Expected to Last for Months, Hardest-Hit Nations Identified

Africa’s Internet Crisis: Massive Outage Could Last Months, These...

FTC Investigates Reddit for AI Content Licensing Practices

FTC is investigating Reddit's plans...

Journalists Criticize AI Hype in Media

Summary Journalists are contributing to the hype and...